Key result
PM2.5 exposure induces cardiac fibrosis via the ERS/TXNIP/NLRP3 pathway, which ERS and TXNIP inhibitors attenuate.
Why the study?
PM2.5 exposure promotes cardiac fibrosis and cardiovascular diseases, but the underlying mechanisms remain unclear.
The ERS/TXNIP/NLRP3 signaling pathway mediates PM2.5-induced cardiac fibrosis via pyroptosis and apoptosis in macrophages and cardiomyocytes, identifying potential therapeutic targets to mitigate environmental cardiovascular risk.
PM2.5 reduction may limit cardiac fibrosis; leaves open ERS/TXNIP/NLRP3 as therapeutic target.
PM2.5 exposure leads to cardiovascular diseases (CVD) by promoting cardiac fibrosis has been demonstrated. However, the mechanisms by which PM2.5 induce cardiac fibrosis remain unclear. Here we confirm that the endoplasmic reticulum stress (ERS)/thioredoxin-interacting protein (TXNIP)/nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) signaling pathway is the mechanism of action in PM2.5-induced cardiac fibrosis, which also plays a crucial role across multiple cell types implicated in this condition. PM2.5 exposure resulted in increased levels of ROS, the occurrence of ERS, upregulation of TXNIP expression, as well as pyroptosis and apoptosis in macrophages and cardiomyocytes, subsequently leading to the activation of MCF. The pyroptosis and apoptosis in macrophages and cardiomyocytes, along with MCF activation induced by PM2.5 were significantly attenuated with the inhibitors of ERS and TXNIP. We also observed that ERS and TXNIP are involved in multiple mechanisms related to oxidative stress and the inflammatory response. We provide insights into the specific mechanisms underlying PM2.5-induced cardiac fibrosis and suggest potential targets for control PM2.5-induced cardiac fibrosis.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied PM2.5-induced cardiac fibrosis. PM2.5 exposure vs. Inhibitors of ERS and TXNIP was evaluated on Mechanisms of PM2.5-induced cardiac fibrosis. PM2.5 exposure induces cardiac fibrosis via the ERS/TXNIP/NLRP3 signaling pathway, leading to pyroptosis and apoptosis in macrophages and cardiomyocytes, which is attenuated by ERS and TXNIP inhibitors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: